MoonLake Immunotherapeutics
MLTX
MLTX
23 hedge funds and large institutions have $190M invested in MoonLake Immunotherapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-4
Holders Change %
-14.81%
% of All Funds
0.39%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
15
Increased
5
Reduced
2
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–